Concepedia

Lawrence Schwartz

LS

Statistics

Publications

26

Citations

2.3K

H-Index

22

Active since

1951

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Mount Sinai Hospital

Tufts Medical Center

University of Pennsylvania

Lawrence Schwartz is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1951–2021

26

Publications

26

Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Manish A. Shah, Ramesh K. Ramanathan, David H. Ilson et al. · Journal of Clinical Oncology · 2006 · 409 citations

, , +15

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

Melanie B. Thomas, Deborah Jaffe, Michael M. Choti et al. · Journal of Clinical Oncology · 2010 · 394 citations

, , +16

Phase II Trial of Bortezomib for Patients With Advanced Renal Cell Carcinoma

G. Varuni Kondagunta, Beverly J. Drucker, Lawrence Schwartz et al. · Journal of Clinical Oncology · 2004 · 193 citations · Full text

, , +17

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Elise A. Olsen, Sean Whittaker, Rein Willemze et al. · Blood · 2021 · 171 citations · Full text

, , +11

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Jennifer E. Amengual, Renee Lichtenstein, Jennifer Kimberly Lue et al. · Blood · 2017 · 134 citations · Full text

, , +8

1–5 of 26